Sodium-glucose cotransporter 2 inhibitors and constipation: a two-sample mendelian randomization study

Read full text Summarise with VIRAT
Authors: Qiuhui Liu, Jing Ning, Zihan Chen, Zihan Wang, Haihua Qian, Dan Zhang, X. Edward Zhou
Cited by: 0
References: 55

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective: Evidence regarding the effect of sodium-glucose cotransporter 2 (SGLT-2) inhibition on constipation is conflicting and the underlying mechanism unknown. We aimed to investigate the causal effect of SGLT-2 inhibition on constipation and the potential mediating role of circulating metabolites. Methods: We conducted a two-sample Mendelian randomization (MR) study. Genetic instruments for SGLT-2 inhibition were constructed from variants associated with SLC5A2 gene expression and glycated hemoglobin (HbA1c) levels. Summary-level data for constipation and 452 circulating metabolites were obtained from large-scale genome-wide association studies (GWAS). The primary analysis used the inverse-variance weighted method, supplemented by extensive sensitivity analyses. A two-step MR approach was applied to quantify mediation. Results: < 0.0001). Of the 452 metabolites examined, DSGEGDFXAEGGGVR was significantly associated with both SGLT-2 inhibition and constipation. Mediation analysis indicated that DSGEGDFXAEGGGVR significantly mediated 22.76% of the protective effect. Conclusion: This study provides genetic support for a causal relationship between SGLT-2 inhibition and reduced constipation risk, and identifies DSGEGDFXAEGGGVR as a potential mediating metabolite. These findings offer insights into a possible pharmacological pathway that may inform future approaches to constipation management.

Fields of Study & Subjects

Genetic Associations and Epidemiology Gastrointestinal motility and disorders Pharmacogenetics and Drug Metabolism

Publication details

Journal / source
Frontiers in Pharmacology
Volume
17
Pages
1742232–1742232
Publication date
23 March 2026
Language
EN